tiprankstipranks
Algernon Pharmaceuticals (TSE:AGN)
:AGN
Canadian Market
Holding TSE:AGN?
Track your performance easily

Algernon Pharmaceuticals Inc (AGN) Financial Statements

34 Followers

Algernon Pharmaceuticals Inc Financial Overview

Algernon Pharmaceuticals Inc's market cap is currently ―. The company's EPS TTM is C$-0.034; its P/E ratio is ―; Algernon Pharmaceuticals Inc is scheduled to report earnings on January 23, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Aug 24May 24Feb 24Nov 23Aug 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -421.43K$ 1.44M$ -1.00M$ -521.55K$ -2.53M
EBITDA$ -416.03K$ 1.45M$ -1.00M$ -514.13K$ -2.51M
Net Income Common Stockholders$ -421.43K$ 1.44M$ -1.00M$ -521.55K$ -2.53M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 125.08K$ 609.52K$ 76.28K$ 74.17K$ 125.08K
Total Assets$ 4.19M$ 3.89M$ 3.95M$ 3.95M$ 4.19M
Total Debt$ ―$ ―$ ―$ ―$ ―
Net Debt$ ―$ ―$ ―$ ―$ ―
Total Liabilities$ 2.72M$ 1.93M$ 3.52M$ 2.94M$ 2.72M
Stockholders Equity$ 1.47M$ 1.96M$ 437.32K$ 1.01M$ 1.47M
Cash Flow-
Free Cash Flow$ -665.27K$ 521.30K---
Operating Cash Flow$ -632.49K$ -1.79M-$ -52.24K-
Investing Cash Flow$ -4.03K$ 2.31M---
Financing Cash Flow$ 628.02K$ 7.50K---
Currency in USD

Algernon Pharmaceuticals Inc Earnings and Revenue History

Algernon Pharmaceuticals Inc Debt to Assets

Algernon Pharmaceuticals Inc Cash Flow

Algernon Pharmaceuticals Inc Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis